Lataa...
Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox)
Innovative approaches for the treatment of rare inherited diseases are hampered by limited availability of patient derived samples for preclinical research. This also applies for the evaluation of novel vector systems for the gene therapy of monogenic hematological diseases like X-linked chronic gra...
Tallennettuna:
| Julkaisussa: | Mol Ther Methods Clin Dev |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362359/ https://ncbi.nlm.nih.gov/pubmed/26015977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2014.37 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|